Johnson & Johnson SPRAVATO — Percent Change (as a percent) increased by 954.5% to 46.4% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from 41.9% to 46.4%. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates accelerating market adoption or price realization, whereas a negative percentage suggests slowing demand, competitive pressure, or potential market contraction.
This metric measures the period-over-period growth rate of revenue for a specific pharmaceutical product line. It provid...
Comparable to year-over-year or quarter-over-quarter product growth rates disclosed by peer pharmaceutical firms to track the performance of key growth drivers.
jnj_segment_spravato_percent_change_as_a_percent| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 86.9% | 98.2% | 82.1% | 72.2% | 60.2% | 54.9% | 41.9% | 53.3% | 61.5% | 4.4% | 46.4% |
| QoQ Change | — | +13.0% | -16.4% | -12.1% | -16.6% | -8.8% | -23.7% | +27.2% | +15.4% | -92.8% | +954.5% |
| YoY Change | — | — | — | -16.9% | -38.7% | -33.1% | -42.0% | -11.5% | +12.0% | — | +10.7% |